Skip to main content
. 2011 Nov 24;14(2):146–150. doi: 10.1093/icvts/ivr029

Table 1:

Clinicopathological factors and AE

Factors AE (−) AE (+) P-values
Total (n) 62 56 6
Age (58–85) 70 ± 6 70 ± 6 72 ± 8 0.509
Gender (n = 62) 0.264
 Male 55 51 4
 Female 7 5 2
CRP (n = 62) 1.08 ± 2.64 0.905 ± 2.15 2.67 ± 5.54 0.121
WBC (×103) (n = 62) 6.91 ± 2.03 6.82 ± 1.99 7.82 ± 2.92 0.254
LDH (n = 62) 200 ± 40 198 ± 37 222 ± 61 0.164
KL-6 (n = 51) 673 ± 438 610 ± 392 1143 ± 518 0.004
Operation time (n = 62) (min) 196 ± 69 191 ± 68 238 ± 69 0.112
Blood loss (n = 62) (ml) 381 ± 522 364 ± 535 545 ± 387 0.423
%VC (n = 62) (%) 99.1 ± 17.5 100.5 ± 17.7 86.2 ± 9.4 0.056
FEV1.0% (n = 62) (%) 77.8 ± 14.2 77.8 ± 14.8 77.8 ± 5.4 0.995
Alcohol (n = 62) 0.999
 − 32 29 3
 + 30 27 3
Emphysema (n = 62) 0.999
 − 24 22 2
 + 38 34 4
Bulla (n = 62) 0.624
 − 51 47 4
 + 11 9 2
Old inflammation (n = 62) 0.999
 − 53 48 5
 + 9 8 1
Fibrosis (n = 62) 0.112
 UIP 7 6 1
 f-NSIP 25 21 4
 c-NSIP 16 15 1
 UFC 14 14 0
Operative procedure (n = 62) 0.414
 Lobectomy 44 39 5
 Segmentectomy 6 5 1
 Partial resection 12 12 0
Pathology (n = 62) 0.518
 Adenoca 29 25 4
 Squamous 22 21 1
 Others 11 10 1
Pathological stage (n = 62) 0.606
 IA 24 21 3
 IB 13 12 1
 IIA 7 7 0
 IIB 9 7 2
 IIIA 8 8 0
 IIIB 0 0 0
 IV 1 1 0